IB

Inhibrx Biosciences

INBX

NASDAQHealth Care

Income Statement

Total Revenue$200K

Operating Income$0

EBITDA$0

EBIT$-331.45M

Pre-tax Income$1.69B

Net Income$1.69B

Balance Sheet

Cash Equivalent$216.52M

Total Debt$98.65M

Book Value$134

Book Value Per Share9.57

Key Ratios

Return on Equity (ROE)+1259.38%

Return on Assets (ROA)+932.36%

Return on Invested Capital (ROI)+1259.38%

Net Profit Margin+843786.00%

Current Ratio3.90

Quick Ratio3.72

Long-Term Debt / Equity4.70